Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) Stock Overview

Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.

TWST●NASDAQ
HealthcareMedical - Diagnostics & Research
$145.59
$9.26(6.79%)
U.S. Market opens in 63h 26m

Twist Bioscience Corporation (TWST)

Meyka AI Score

Z

Key Financials

Market Cap9.1B
P/E Ratio-64.81
EPS (TTM)$-2.22
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$126.88
3 Months$112.36
1 Year Target$40.96

TWST Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Twist Bioscience Corporation (NASDAQ: TWST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Twist Bioscience Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TWST on the NASDAQ shows an RSI of 69.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $40.96 for the NASDAQ listing.

Key metrics behind Twist Bioscience Corporation's NASDAQ-traded stock include a P/E ratio of -64.81 and a market capitalization of 9.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TWST on the NASDAQ.

Price Performance (NASDAQ: TWST)

1-Day Change
6.79%
5-Day Change
17.33%
1-Month Change
51.88%
3-Month Change
147.43%
6-Month Change
199.63%
Year-to-Date (YTD) Change
358.98%
1-Year Change
450.02%
3-Year Change
651.24%
5-Year Change
34.69%
All-Time (Max) Change
939.93%

Contact Information

https://www.twistbioscience.com
800 719 0671
681 Gateway Boulevard, South San Francisco, CA, 94080

Company Facts

9,790 Employees
IPO DateOct 31, 2018
CountryUS
Actively Trading

Frequently Asked Questions